Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 5
2014 12
2015 6
2019 2
2020 3
2021 5
2022 11
2023 9
2024 5
2025 13
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Lung Cancer in Turkey.
Cangır AK, Yumuk PF, Sak SD, Akyürek S, Eralp Y, Yılmaz Ü, Selek U, Eroğlu A, Tatlı AM, Dinçbaş FÖ, Kılıçkap S, Şendur MAN, Dilektaşlı AG, Bozcuk HŞ, Özkök S, Öztop İ, Topkan E, Dilege Ş, Kaya A, Demirkazık A; Turk Oncology Group. Cangır AK, et al. Among authors: tatli am. J Thorac Oncol. 2022 Oct;17(10):1158-1170. doi: 10.1016/j.jtho.2022.06.001. J Thorac Oncol. 2022. PMID: 36192076 Free article. No abstract available.
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.
Tural D, Özkan O, Eylemer Mocan E, Kapar C, Yaslikaya S, Tatlı AM, Akdağ G, Demir H, Bilgetekin I, Selcukbiricik F, Köse F, Sari M, Erdem GU, Sucuoğlu İşleyen Z, Arslan C, Celik S, Evrensel T, Erman M, Kazaz SN, Ozturk B, Çelik H, Özen M, Erel P, Can Şancı P, Ergün Y, Taban H, Kuzu ÖF, Ulaş Kahya B, Arslan AM, Sakin A, Araz M, Okutur K, Akgül F, Mirili C, Sevinç A, Atalah F, Düzköprü Y, Gülbağcı B, Yaşar S, Kandemir N, Kosku H, Aydın E, Erdem D, Guliyev M, Çulha Y, Şahin B, Gürsoy P, Ürün Y. Tural D, et al. Among authors: tatli am. Future Oncol. 2025 Nov;21(27):3499-3505. doi: 10.1080/14796694.2025.2570637. Epub 2025 Oct 16. Future Oncol. 2025. PMID: 41103123
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group.
Telli TA, Tatlı AM, Alan Ö, Keskin GY, Karadurmuş N, Karakaya S, Kaplan MA, Açıkgöz Ö, Bilici A, Mocan EE, Demirkazık A, Kahraman S, Şendur MA, Doğan M, Selam MT, Er Ö, Ünsal O, Yazıcı O, Özcan E, Kargı A, Gürbüz M, Selçukbiricik F, Şakalar T, Gürsoy P, Bilgin B, Selvi O, Karadağ İ, Eren OÖ, Bayram E, Sümbül AT, Keskin S, Öztürk A, Topçu S, Özen M, Kılıçkap S, Yumuk PF. Telli TA, et al. Among authors: tatli am. Clin Lung Cancer. 2025 Dec;26(8):e649-e659. doi: 10.1016/j.cllc.2025.07.015. Epub 2025 Jul 22. Clin Lung Cancer. 2025. PMID: 40813186
Prognostic Role of Inflammatory and Nutritional Indices in NSCLC Patients Treated with Immune Checkpoint Inhibitors: Retrospective, Multicenter, Turkish Oncology Group Study of Overall and Elderly Populations.
Alan O, Telli TA, Akbas S, Isik S, Çavdar E, Karaboyun K, Merc Cetinkaya A, Ekinci F, Erdoğan AP, Büyükşimsek M, Er MM, Karakurt Eryilmaz M, Güçlü Kantar T, Gököz Doğu G, Sakalar T, Bayram E, Inal A, Akdağ Kahvecioğlu F, Hacibekiroğlu İ, Selçukbiricik F, Tatli AM, Yumuk PF. Alan O, et al. Among authors: tatli am. Medicina (Kaunas). 2025 Jun 26;61(7):1160. doi: 10.3390/medicina61071160. Medicina (Kaunas). 2025. PMID: 40731790 Free PMC article.
Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?
Güner G, Aktaş BY, Başal FB, Demirkazık A, Gürsoy P, Demirci U, Erman M, Yumuk PF, Şenler FÇ, Çakar B, Çiçin İ, Öztürk A, Coşkun HŞ, Çubukçu E, Işıkdoğan A, Ölmez ÖF, Tatlı AM, Karaağaç M, Şakalar T, Eralp Y, Korkmaz T, Kılıçkap S. Güner G, et al. Among authors: tatli am. J Cancer Res Clin Oncol. 2023 Nov;149(14):13271-13277. doi: 10.1007/s00432-023-05190-3. Epub 2023 Jul 22. J Cancer Res Clin Oncol. 2023. PMID: 37480524 Free PMC article.
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.
Ünal Ç, Azizy A, Karabulut S, Taştekin D, Akyıldız A, Yaşar S, Yalçın Ş, Çoban E, Evrensel T, Kalkan Z, Oruç Z, Derin S, Turna ZH, Bayram D, Köş FT, Şendur MAN, Sever N, Ercelep Ö, Seyyar M, Kefeli U, Uygun K, Özçelik M, Ön S, Şanlı UA, Canaslan K, Ünek İT, Yücel KB, Özdemir N, Yazıcı O, Güzel HG, Salim DK, Göksu SS, Tatlı AM, Ordu Ç, Selvi O, Sakin A, Büyükbayram ME, Dursun B, Ürün Y, Arak H, Ağdaş G, Uğraklı M, Hendem E, Eryılmaz MK, Bilgin B, Topçu A, Şimşek M, Büyükşimşek M, Akay B, Erdal GŞ, Karataş F, Alan Ö, Çağlayan M, Kahvecioğlu FA, Demirci A, Paksoy N, Çetin B, Gümüş M, Ak N, Aydınalp Y, Paydaş S, Güven DC, Kılıçkap S, Sağlam S. Ünal Ç, et al. Among authors: tatli am. Oncologist. 2023 Oct 3;28(10):875-884. doi: 10.1093/oncolo/oyad257. Oncologist. 2023. PMID: 37676712 Free PMC article.
71 results